Levin Capital Strategies, L.P. Prime Medicine, Inc. Transaction History

Levin Capital Strategies, L.P.

$990 Million
Q2 2025

A detailed history of Levin Capital Strategies, L.P. transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 140,000 shares of PRME stock, worth $900,200. This represents 0.03% of its overall portfolio holdings.

Number of Shares

140,000

Previous 35,000 300.0%

Holding current value

$900,200

Previous $69,000 400.0%

% of portfolio

0.03%

Previous 0.01%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$1.15 - $2.65 $120,749 - $278,250	105,000 Added 300.0%	140,000 $345,000
Q1 2025 May 09, 2025	SELL	$1.72 - $3.35 $68,800 - $134,000	-40,000 Reduced 53.33%	35,000 $69,000
Q4 2024 Feb 05, 2025	BUY	$2.64 - $4.46 $118,800 - $200,700	45,000 Added 150.0%	75,000 $219,000
Q3 2024 Nov 13, 2024	BUY	$3.41 - $6.7 $102,300 - $201,000	30,000 New	30,000 $116,000
Q1 2024 May 16, 2024	BUY	$6.35 - $9.39 $41,275 - $61,035	6,500 Added 32.5%	26,500 $185,000
Q4 2023 Feb 06, 2024	BUY	$5.59 - $9.55 $111,800 - $191,000	20,000 New	20,000 $177,000
Q2 2023 Jul 31, 2023	BUY	$11.41 - $17.05 $228,200 - $341,000	20,000 New	20,000 $293,000
Q4 2022 Feb 13, 2023	BUY	$15.2 - $21.12 $160,892 - $223,555	10,585 New	10,585 $196,000

Others Institutions Holding PRME

# of Institutions

133

Shares Held

56M

Call Options Held

182K

Put Options Held

211K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $616M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account

Levin Capital Strategies, L.P. Prime Medicine, Inc. Transaction History